Rebirthel provides a novel treatment method "Allogeneic off-the-shelf universal T cell therapy" for advanced and recurrent cancers that are not curative to current conventional therapies.
Fundamental technologies that make this therapy realizable are patented globally. With the recently developed technology to avoid immune rejection, we provide the super universal therapy with benefits to patients.
This is some text inside of a div block.
